The Addition of Apalutamide to ADT in the Treatment of Metastatic Castration-Sensitive Prostate Cancer: Safety and Efficacy

Expert Review of Anticancer Therapy- United Kingdom

doi 10.1080/14737140.2020.1732212

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Pcn37 - Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Apalutamide for the Treatment of Non‐metastatic Prostate Cancer

Prescriber
Pharmacology
2019English

Abiraterone in Metastatic Castration-Resistant Prostate Cancer: Efficacy and Safety in Unselected Patients

Cancer Treatment and Research Communications
Cancer ResearchOncology
2018English

Pcn153 - Cost-Effectiveness Analysis of Apalutamide for Treatment in Non- Metastasis Castration-Resistant Prostate Cancer

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-Resistant Prostate Cancer After Chemotherapy

Klinicka Onkologie
Oncology
2016English

Adjusting Overall Survival Estimates for Treatment Switching in Metastatic, Castration-Sensitive Prostate Cancer: Results From the LATITUDE Study

Targeted Oncology
Cancer ResearchOncologyPharmacology
2019English

Practical Guidance on the Role of Corticosteroids in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Urology
Urology
2016English

Metastatic Castration-Resistant Prostate Cancer: The Emerging Continuum of Care

Journal of the Canadian Urological Association
OncologyUrology
2013English

Radium223—Where Does It Fit in the Metastatic Castration-Resistant Prostate Cancer Treatment Landscape?

Oncology & Hematology Review (US)
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy